Dulaglutide: all 80 studies that test it

Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney DiseaseNot yet recruitingNCT07537088Phase 4
• Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes MellitusEnrolling by invitationNCT07319286Phase 1/2
• Role of GLP1 RA Dulaglutide on Severe Intracranial AtherosclerosisRecruitingNCT07282041Phase 2/3
• A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)RecruitingNCT06739122Phase 3
• The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With ObesityRecruitingNCT06331286Not applicable
• GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac SurgeryRecruitingNCT06324461Phase 4
• Therapeutic Strategies for Microvascular Dysfunction in Type 1 DiabetesRecruitingNCT05478707Phase 2
• Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2DNot yet recruitingNCT05140694Phase 4
• GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose IntoleranceRecruitingNCT04731272Phase 2
• A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in IndiaCompletedNCT05659537Phase 4Results posted
• Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney DiseaseCompletedNCT05254418Phase 2Results posted
• Perioperative Stress Hyperglycemia in General and Vascular Surgery PatientsTerminatedNCT04862234Phase 4Results posted
• A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesCompletedNCT04809220Phase 3Results posted
• A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 DiabetesCompletedNCT04591626Phase 3Results posted
• GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic ResponseCompletedNCT04387201Phase 4Results posted
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesCompletedNCT04255433Phase 3Results posted
• Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide scCompletedNCT04189848Phase 4Results posted
• Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery PatientsTerminatedNCT03743025Phase 4Results posted
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 DiabetesCompletedNCT03495102Phase 3Results posted
• A Study of Dulaglutide in Healthy ParticipantsCompletedNCT03363906Phase 1Results posted
• A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 DiabetesCompletedNCT03315780Phase 4Results posted
• A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyCompletedNCT02973100Phase 2Results posted
• A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 DiabetesCompletedNCT02963766Phase 3Results posted
• A Study of Dulaglutide in Japanese Participants With Type 2 DiabetesCompletedNCT02750410Phase 4Results posted
• A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusCompletedNCT02597049Phase 3Results posted
• A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesCompletedNCT02152371Phase 3Results posted
• Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)CompletedNCT01769378Phase 3Results posted
• A Study of Dulaglutide in Chinese ParticipantsCompletedNCT01667900Phase 1Results posted
• A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT01648582Phase 3Results posted
• A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes MellitusCompletedNCT01644500Phase 3Results posted
• A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 DiabetesCompletedNCT01624259Phase 3Results posted
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)CompletedNCT01621178Phase 3Results posted
• A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01584232Phase 3Results posted
• A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01558271Phase 3Results posted
• A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual SyringeCompletedNCT01524770Phase 1Results posted
• A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female ParticipantsCompletedNCT01458210Phase 1Results posted
• A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy ParticipantsCompletedNCT01436201Phase 1Results posted
• A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy ParticipantsCompletedNCT01432938Phase 1Results posted
• A Study of LY2189265 and Sitagliptin in Participants With Type 2 DiabetesCompletedNCT01408888Phase 1Results posted
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)CompletedNCT01394952Phase 3Results posted
• A Study of the Effect of LY2189265 on Two Blood Pressure DrugsCompletedNCT01324388Phase 1Results posted
• A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.CompletedNCT01301092Phase 1Results posted
• Effect of LY2189265 on Insulin Secretion in Response to Intravenous GlucoseCompletedNCT01300260Phase 1Results posted
• A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) ImpairmentCompletedNCT01253304Phase 1Results posted
• LY2189265 and Atorvastatin Interaction StudyCompletedNCT01250834Phase 1Results posted
• A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes MellitusCompletedNCT01215968Phase 1Results posted
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)CompletedNCT01191268Phase 3Results posted
• A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesCompletedNCT01149421Phase 2Results posted
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)CompletedNCT01126580Phase 3Results posted
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)CompletedNCT01075282Phase 3Results posted
• A Study in Participants With Type 2 Diabetes MellitusCompletedNCT01064687Phase 3Results posted
• A Study of LY2189265 in Japanese Patients With Type 2 DiabetesCompletedNCT01001104Phase 2Results posted
• Effects of LY2189265 on Glycemic Control in Participants With Type 2 DiabetesCompletedNCT00791479Phase 2Results posted
• A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on MetforminCompletedNCT00734474Phase 2/3Results posted
• A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes MellitusCompletedNCT00630825Phase 2Results posted
• Weekly GLP-1 Receptor Agonists in Obese Individuals Without DiabetesCompletedNCT07834398Phase 3
• Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical TrialCompletedNCT07820111Phase 3
• Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent ThalassemiaCompletedNCT07370922Phase 2
• A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes MellitusCompletedNCT07313813Phase 1
• Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.CompletedNCT06851962Phase 4
• The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and AlbuminuriaActive, not recruitingNCT06611904Not applicable
• A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes MellitusCompletedNCT06235086Phase 3
• Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic NephropathyCompletedNCT06182891Not applicable
• A Study of IBI362 in Participants With Type 2 DiabetesCompletedNCT05606913Phase 3
• A Study of LY3532226 in Participants With Type 2 Diabetes MellitusCompletedNCT05407961Phase 1
• A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 DiabetesCompletedNCT05377333Phase 1
• Basal Plus GLP1-ra on Glycemic Variability in CKDCompletedNCT05218915Phase 4
• Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 DiabetesStatus unknownNCT04893148Phase 4
• GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)CompletedNCT04876027Phase 4
• Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using MetforminCompletedNCT04829903Not applicable
• Effects of Glucagon-Like Peptide-1 Analogs on SexualityCompletedNCT04687514Phase 2
• A Study of LY3457263 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT04641312Phase 1
• Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory VariablesCompletedNCT03824002Phase 4
• Dulaglutide and Insulin MicrosecretiON in Type 1 DiabetesCompletedNCT03668470Phase 2
• Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)Status unknownNCT03648554Phase 4
• Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseCompletedNCT03590626Not applicable
• Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 DiabetesStatus unknownNCT03444142Phase 4
• Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) AnaloguesCompletedNCT03204396Phase 2
• Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid IntakeCompletedNCT03141632Phase 2
• Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)CompletedNCT02770885Phase 2

← Dulaglutide overview